Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Cancer|July 15, 1993
K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lungW H Westra, R J Slebos, G J Offerhaus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
A simple system for grading the response of breast cancer to neoadjuvant chemotherapyS Rodenhuis, I A M Mandjes, J Wesseling, et al.
Breast Cancer Research and Treatment|January 1, 1996
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyE H Lips, L Mulder, J Hannemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancerS Rodenhuis, L T Vlasveld, R Dubbelman, et al.
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupP J Woll, I Judson, S M Lee, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapyA M M Oonk, C van Rijn, M M Smits, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Cancer|July 15, 1993
K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lungW H Westra, R J Slebos, G J Offerhaus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
A simple system for grading the response of breast cancer to neoadjuvant chemotherapyS Rodenhuis, I A M Mandjes, J Wesseling, et al.
Breast Cancer Research and Treatment|January 1, 1996
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyE H Lips, L Mulder, J Hannemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancerS Rodenhuis, L T Vlasveld, R Dubbelman, et al.
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupP J Woll, I Judson, S M Lee, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapyA M M Oonk, C van Rijn, M M Smits, et al.
Pageof 15